Novo Nordisk (NVO) makes Ozempic, the best-known GLP-1 drug out today. And until quite recently, the Danish pharma giant consistently led the pack in new prescriptions, becoming virtually synonymous w [...]
Like untold millions of smartphone users, I have a bit of a problem. I’ve been trying, with middling success, to be more mindful about how I use my phone. I’ll often uninstall various social media [...]
London-headquartered biotech startup Verdiva has emerged from stealth with a whopping $410mn for a new range of drugs aimed at tackling the obesity epidemic. It’s one of Europe’s largest-ever biot [...]
The next big trend in AI providers appears to be "studio" environments on the web that allow users to spin up agents and AI applications within minutes. Case in point, today the well-funded [...]